Product
Intralipid
Aliases
Intralipid, 20% Intravenous Emulsion
10 clinical trials
15 indications
Indication
Essential Fatty Acid DeficiencyIndication
MalnutritionIndication
PediatricIndication
AnesthesiaIndication
LocalIndication
Organophosphorus PoisoningIndication
Diabetes MellitusIndication
Type 2Indication
Insulin ResistanceIndication
Insulin SensitivityIndication
ObesityIndication
infertilityIndication
Hypogonadotropic HypogonadotropismIndication
HyperinsulinemiaClinical trial
A Randomized, Double-Blind, Controlled, Clinical Trial to Evaluate the Risk of Developing Essential Fatty Acid Deficiency in Pediatric Patients, Including Neonates, Receiving Either Clinolipid (Lipid Injectable Emulsion, USP) 20% or Standard-of-Care Soybean Oil-Based Lipid Emulsion (Part A)Status: Completed, Estimated PCD: 2022-10-16
Clinical trial
Prospective, Randomized (1:1), Double-Blind, Parallel-Group, Active-Controlled, Multicenter Study to Compare Safety and Efficacy of Smoflipid to Intralipid 20% in Pediatric Patients of 3 Months to 16 Years of Age Requiring Parenteral Nutrition for at Least 90 Days and up to 1 YearStatus: Terminated, Estimated PCD: 2020-11-12
Clinical trial
The Use of Intralipid® 20% Solution to Reverse the Anesthetic Effect of Local Anesthetics: a Proof of Concept Study in VolunteersStatus: Recruiting, Estimated PCD: 2024-10-01
Clinical trial
Role of Intralipid in Management of Organophosphorus PoisoningStatus: Not yet recruiting, Estimated PCD: 2025-11-01
Clinical trial
A Dose Finding Study for Fat-Induced Insulin Resistance in Healthy VolunteersStatus: Recruiting, Estimated PCD: 2025-01-01
Clinical trial
Bilirubin Neurotoxicity (BN) and Neurodevelopmental Impairment (NDI) in Extremely Preterm (EP) Infants: Avoidable by Reducing the Usual Intravenous Lipid (UL) AdministrationStatus: Recruiting, Estimated PCD: 2024-06-30
Clinical trial
Reprometabolic Syndrome Mediates Subfertility in ObesityStatus: Completed, Estimated PCD: 2022-01-11
Clinical trial
Comparison of Composite Lipid Emulsion Containing Fish Oil to Soy-based Lipid Reduction for Cholestasis Prevention in Neonates Requiring Abdominal SurgeryStatus: Active (not recruiting), Estimated PCD: 2021-03-28
Clinical trial
Investigating Whether Acute Elevation of Fatty Acid Levels Alters Cerebral Glucose Transport and MetabolismStatus: Recruiting, Estimated PCD: 2025-06-01